Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry, ENSG00000225297, is a pseudogene with high sequence similarity to part of the aldo-keto reductase family 1, member B1 (also known as aldose reductase, gene symbol AKR1B1), but lacks the capacity to encode a functional protein product due to disabling mutations or loss of regulatory elements. Pseudogenes are common in the genome and typically do not participate in any cellular function, although rare pseudogenes in some gene families can produce regulatory RNAs or interfere with related transcripts. No such activity or functional role has been described for this specific locus. Pseudogenes are not considered direct therapeutic targets, nor do they have established disease roles or drug interactions. They may cause artifacts or confusion in molecular genetics studies if mistaken for their functional homologs, but generally have no clinical utility.
None. As no drugs interact with this pseudogene, there are no mechanisms of action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of aldo-keto reductase family 1, member B1 (ENSG00000225297).